Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
4
2015
Second Circuit Holds a Hard Switch Between Drugs Is an Unlawful Product Hop Under Section 2 Mintz
Jun
4
2015
Federal Circuit Hears Oral Arguments in Neupogen Biosimilar Case Foley & Lardner LLP
Jun
3
2015
Multiple DWI Convictions Don’t Create A “Record of” Alcoholism Under ADA; Driving Restrictions Don’t Support “Regarded As” Claim Jackson Lewis P.C.
Jun
2
2015
Big Win for Anti-GMO Groups as Oregon Federal Judge Upholds Jackson County GMO Ban Mintz
Jun
2
2015
FTC’s $1.2 Billion Disgorgement Settlement With Cephalon: Heightened Scrutiny of Hatch-Waxman Settlements Foley & Lardner LLP
Jun
2
2015
New Regulations in the Administration of Buprenorphine, Part One McBrayer, McGinnis, Leslie and Kirkland, PLLC
Jun
2
2015
Cosmetic Safety Legislation Introduced, Again Beveridge & Diamond PC
Jun
2
2015
Another Sequenom Patent Appeal Heads To The Federal Circuit Foley & Lardner LLP
Jun
2
2015
Second Circuit Requires Manufacturer to Continue Selling Old Version of Drug to Prevent Anticompetitive "Product Hopping" ArentFox Schiff LLP
Jun
2
2015
Medical Marijuana and Gaming: To Divest or Not to Divest? Dickinson Wright PLLC
Jun
1
2015
In Affirming a Preliminary Injunction Against Drug Companies, Second Circuit Finds Coercion in Product Hopping Scheme American University Washington College of Law
May
30
2015
FDA Poised to Ban Most Trans Fats ArentFox Schiff LLP
May
29
2015
Italian Competition Authority Launches Sector Inquiry in Re: Vaccines For Human Use Covington & Burling LLP
May
28
2015
GMOs at the Ballot Box: the Drama Continues Mintz
May
27
2015
FDA Issues Draft Guidance on Use of Patient Preference Information in Certain Medical Device Pre-market Submissions and Labeling Barnes & Thornburg LLP
May
27
2015
FDA Issues Draft Guidance on Mandatory Food Recalls Under the Food Safety Modernization Act Barnes & Thornburg LLP
May
27
2015
Dependent Claims Give Rise To Improper Broadening Reissue re: Patent Applications Foley & Lardner LLP
May
26
2015
House Subcommittee Circulates Proposed Legislation Providing Insight on the Future of the 340B Drug Pricing Program McDermott Will & Emery
May
22
2015
Second Circuit Affirms Preliminary Injunction in Antitrust Suit Against Drug Companies for "Product Hopping" American University Washington College of Law
May
22
2015
UPDATE: Ice Cream Recall Begets First Lawsuit ArentFox Schiff LLP
May
21
2015
Life Sciences Congressional Investigations: Trends, Traps and Tips Tycko & Zavareei LLP
May
21
2015
Apotex Petitions Supreme Court to Review Therasense Standards Schwegman, Lundberg & Woessner, P.A.
May
21
2015
Patent Safe Harbor Applies To Supplemental New Drug Applications Foley & Lardner LLP
May
20
2015
Maker’s Marketing: Bourbon Distiller Racks up “Handmade” False Advertising Victory Proskauer Rose LLP
May
20
2015
Alcohol Tax Breaks Brewing In Congress - May 2015 McBrayer, McGinnis, Leslie and Kirkland, PLLC
May
19
2015
Private Lives v Saving Lives: Privacy Intrusions Of Little Consequence When Drug Testing in Australia Squire Patton Boggs (US) LLP
May
19
2015
Federal Circuit Finds No Direct Infringement Of Akamai Patents Foley & Lardner LLP
May
18
2015
The Sixth Circuit Reins in the Government's Measure of False Claims Act Damages Katten
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins